Login
$GTM
$4.27 -$0.08 (1.84%) Close

Consolidated Balance Sheets

In millions of USD, except per-share amounts
Q2 FY2026
As of Jun 30, 2026
Q1 FY2026
As of Mar 31, 2026
Q4 FY2025
As of Dec 31, 2025
Q3 FY2025
As of Sep 30, 2025
Q2 FY2025
As of Jun 30, 2025
Q1 FY2025
As of Mar 31, 2025
Q4 FY2024
As of Dec 31, 2024
Q3 FY2024
As of Sep 30, 2024
Q2 FY2024
As of Jun 30, 2024
Q1 FY2024
As of Mar 31, 2024
Q4 FY2023
As of Dec 31, 2023
Q3 FY2023
As of Sep 30, 2023
Q2 FY2023
As of Jun 30, 2023
Q1 FY2023
As of Mar 31, 2023
Q4 FY2022
As of Dec 31, 2022
Q3 FY2022
As of Sep 30, 2022
Q2 FY2022
As of Jun 30, 2022
Q1 FY2022
As of Mar 31, 2022
Q4 FY2021
As of Dec 31, 2021
Q3 FY2021
As of Sep 30, 2021
Assets
Current assets:
Cash and cash equivalents
Short-term investments
Restricted cash, current
Accounts receivable, net
Prepaid expenses and other current assets
Income tax receivable
Total current assets
Restricted cash, non-current
Property and equipment, net
Operating lease right-of-use assets, net
Intangible assets, net
Goodwill
Deferred tax assets
Deferred costs and other assets, net of current portion
Total assets
Liabilities and Stockholders’ Equity
Current liabilities:
Accounts payable
Accrued expenses and other current liabilities
Unearned revenue, current portion
Income taxes payable
Current portion of tax receivable agreements liability
Current portion of operating lease liabilities
Current portion of long-term debt
Total current liabilities
Unearned revenue, net of current portion
Tax receivable agreements liability, net of current portion
Operating lease liabilities, net of current portion
Long-term debt, net of current portion
Deferred tax liabilities
Other long-term liabilities
Total liabilities
Stockholders' Equity:
Common stock, par value $0.01; 3,300,000,000 shares authorized as of June 30, 2026 and December 31, 2025; 292,312,307 and 307,293,985 issued and outstanding as of June 30, 2026 and December 31, 2025, respectively
Total common stock, par value $0.01; 3,300,000,000 shares authorized as of June 30, 2026 and December 31, 2025; 292,312,307 and 307,293,985 issued and outstanding as of June 30, 2026 and December 31, 2025, respectively
Preferred stock, par value $0.01; 200,000,000 shares authorized as of June 30, 2026 and December 31, 2025; zero issued and outstanding as of June 30, 2026 and December 31, 2025
Additional paid-in capital (“APIC”)
Accumulated other comprehensive income (“AOCI”)
Retained earnings (deficit)
Total stockholders' equity
Total liabilities and stockholders' equity

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support